Hemorrhagic Cystitis in Allogeneic Stem Cell Transplantation: A Role for Age and Prostatic Hyperplasia

    February 2022 in “ Supportive Care in Cancer
    Eugenio Galli, Federica Sorà, L. Di Gianfrancesco, Sabrina Giammarco, Elisabetta Metafuni, Maria Assunta Limongiello, Idanna Innocenti, Francesco Autore, Luca Laurenti, Patrizia Chiusolo, Andrea Bacigalupo, Simona Sica
    Image
    Studysummary This study found that age is the most significant risk factor for hemorrhagic cystitis after hematopoietic stem-cell transplantation, with additional risk factors including cyclophosphamide-based prophylaxis and, among male recipients, prostatic hyperplasia.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →

    Research cited in this study

    1 / 1 results